Betaine 500mg tablets
Requires a prescription from a doctor or prescriber
Betaine is a methyl group donor that functions in the normal metabolic cycle of methionine.
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Suspected adverse reactions reported for Betaine
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
View EudraVigilance report
Suspected adverse reactions reported for Betaine
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
WHO defined daily dose (DDD)
6 gram
Not a recommended dose. The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. It is a statistical measure used for research and comparison purposes only.
Source: WHO Collaborating Centre for Drug Statistics Methodology, distributed via the NHS dm+d supplementary BNF/ATC mapping files (NHSBSA). Contains public sector information licensed under the Open Government Licence v3.0.
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Guidelines from the National Institute for Health and Care Excellence
NICE clinical guidance(1)
Source: National Institute for Health and Care Excellence (NICE). Contains public sector information licensed under the Open Government Licence v3.0.
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
Browse tools
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary. ATC codes from the WHO Collaborating Centre for Drug Statistics Methodology (whocc.no).
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing all 30 studies.
Reviews & meta-analyses: 12 · 2007–2024
Showing all 30 studies, sorted by most relevant.
Guangfu Zhao, Fang He, Chenlu Wu, et al.
Frontiers in Immunology, 2018
- Anti-Inflammatory Agents
- Betaine
- Energy Metabolism
Betaine is known as trimethylglycine and is widely distributed in animals, plants, and microorganisms. Betaine is known to function physiologically as an important osmoprotectant and methyl group donor. Accumulating evidence has shown that betaine has anti-inflammatory functions in numerous diseases. Mechanistically, betaine ameliorates sulfur amino acid metabolism against oxidative stress, inhibits nuclear factor-κB activity and NLRP3 inflammasome activation, regulates energy metabolism, and mitigates endoplasmic reticulum stress and apoptosis. Consequently, betaine has beneficial actions in several human diseases, such as obesity, diabetes, cancer, and Alzheimer's disease.
Abstract licence: CC BY
M. Annunziata, L. Ciarmiello, P. Woodrow, et al.
Frontiers in Plant Science, 2019
Several halophytes and a few crop plants, among which Poaceae, synthesize and accumulate glycine betaine (GB) in response to environmental constraints. GB has an important role in osmoregulation, in fact, it is one of the main nitrogen-containing compatible osmolytes found in Poaceae. It can interplay with molecules and structures preserving the activity of macromolecules, maintaining the integrity of membranes against stresses and scavenging ROS. Exogenous GB applications have been proved to induce the expression of genes involved in oxidative stress responses, with a restriction of ROS accumulation and lipid peroxidation in cultured tobacco cells under drought and salinity, even stabilizing photosynthetic structures under stress. In the plant kingdom, GB is synthesized from choline by two-step oxidation reactions. The first oxidation is catalyzed by choline monooxygenase (CMO) and the second oxidation is catalyzed by NAD+-dependent betaine aldehyde dehydrogenase (BADH). Moreover, in plants, the cytosolic enzyme, named N-methyltransferase (PEAMT), catalyzes the conversion of phosphoethanolamine to phosphocholine. However, changes in CMO expression genes under abiotic stresses have been observed. GB accumulation is ontogenetically controlled since it happens in young tissues during prolonged stress, while its degradation is generally not significant in plants. This ability of plants to accumulate high levels of GB in young tissues under abiotic stresses is independent of nitrogen (N) availability and supports the view that plant N allocation is dictated primarily to supply and protect the growing tissues even under N limitation. Indeed, the contribution of GB to osmotic adjustment and ionic and oxidative stress defense in young tissues is much higher than that in older ones. In this review, the biosynthesis and accumulation of GB in plants under several abiotic stresses are analyzed focusing the attention on all the possible roles this metabolite can play, in particular in young tissues.
Abstract licence: CC BY
M. Arumugam, Matthew C. Paal, T. Donohue, et al.
Biology, 2021
Medicinal herbs and many food ingredients possess favorable biological properties that contribute to their therapeutic activities. One such natural product is betaine, a stable, nontoxic natural substance that is present in animals, plants, and microorganisms. Betaine is also endogenously synthesized through the metabolism of choline or exogenously consumed through dietary intake. Betaine mainly functions as (i) an osmolyte and (ii) a methyl-group donor. This review describes the major physiological effects of betaine in whole-body health and its ability to protect against both liver- as well as non-liver-related diseases and conditions. Betaine's role in preventing/attenuating both alcohol-induced and metabolic-associated liver diseases has been well studied and is extensively reviewed here. Several studies show that betaine protects against the development of alcohol-induced hepatic steatosis, apoptosis, and accumulation of damaged proteins. Additionally, it can significantly prevent/attenuate progressive liver injury by preserving gut integrity and adipose function. The protective effects are primarily associated with the regulation of methionine metabolism through removing homocysteine and maintaining cellular SAM:SAH ratios. Similarly, betaine prevents metabolic-associated fatty liver disease and its progression. In addition, betaine has a neuroprotective role, preserves myocardial function, and prevents pancreatic steatosis. Betaine also attenuates oxidant stress, endoplasmic reticulum stress, inflammation, and cancer development. To conclude, betaine exerts significant therapeutic and biological effects that are potentially beneficial for alleviating a diverse number of human diseases and conditions.
Abstract licence: CC BY
M. Ashraf, M. Foolad
Environmental and Experimental Botany, 2007
D. Dobrijević, K. Pastor, Nataša M. Nastić, et al.
Molecules, 2023
- Betaine
- Diet
- Whole Grains
Betaine is a non-essential amino acid with proven functional properties and underutilized potential. The most common dietary sources of betaine are beets, spinach, and whole grains. Whole grains-such as quinoa, wheat and oat brans, brown rice, barley, etc.-are generally considered rich sources of betaine. This valuable compound has gained popularity as an ingredient in novel and functional foods due to the demonstrated health benefits that it may provide. This review study will provide an overview of the various natural sources of betaine, including different types of food products, and explore the potential of betaine as an innovative functional ingredient. It will thoroughly discuss its metabolic pathways and physiology, disease-preventing and health-promoting properties, and further highlight the extraction procedures and detection methods in different matrices. In addition, gaps in the existing scientific literature will be emphasized.
Abstract licence: CC BY
I. Aroso, Alexandre Paiva, R. Reis, et al.
Journal of Molecular Liquids, 2017
Shafaqat Ali, Zohaib Abbas, M. Seleiman, et al.
Plants, 2020
Unexpected biomagnifications and bioaccumulation of heavy metals (HMs) in the surrounding environment has become a predicament for all living organisms together with plants. Excessive release of HMs from industrial discharge and other anthropogenic activities has threatened sustainable agricultural practices and limited the overall profitable yield of different plants species. Heavy metals at toxic levels interact with cellular molecules, leading towards the unnecessary generation of reactive oxygen species (ROS), restricting productivity and growth of the plants. The application of various osmoprotectants is a renowned approach to mitigate the harmful effects of HMs on plants. In this review, the effective role of glycine betaine (GB) in alleviation of HM stress is summarized. Glycine betaine is very important osmoregulator, and its level varies considerably among different plants. Application of GB on plants under HMs stress successfully improves growth, photosynthesis, antioxidant enzymes activities, nutrients uptake, and minimizes excessive heavy metal uptake and oxidative stress. Moreover, GB activates the adjustment of glutathione reductase (GR), ascorbic acid (AsA) and glutathione (GSH) contents in plants under HM stress. Excessive accumulation of GB through the utilization of a genetic engineering approach can successfully enhance tolerance against stress, which is considered an important feature that needs to be investigated in depth.
Abstract licence: CC BY
Shima Khodaverdian, B. Dabirmanesh, A. Heydari, et al.
International journal of biological macromolecules, 2018
- Betaine
- Choline
- Enzyme Stability
Veena T. Kelleppan, J. P. King, C. S. Butler, et al.
Advances in colloid and interface science, 2021
Manan Bhatt, Angela Di Iacovo, T. Romanazzi, et al.
Basic & Clinical Pharmacology & Toxicology, 2023
- Betaine
- Brain
- Neurons
The role of betaine in the liver and kidney has been well documented, even from the cellular and molecular point of view. Despite literature reporting positive effects of betaine supplementation in Alzheimer's, Parkinson's and schizophrenia, the role and function of betaine in the brain are little studied and reviewed. Beneficial effects of betaine in neurodegeneration, excitatory and inhibitory imbalance and against oxidative stress in the central nervous system (CNS) have been collected and analysed to understand the main role of betaine in the brain. There are many 'dark' aspects needed to complete the picture. The understanding of how this osmolyte is transported across neuron and glial cells is also controversial, as the expression levels and functioning of the known protein capable to transport betaine expressed in the brain, betaine-GABA transporter 1 (BGT-1), is itself not well clarified. The reported actions of betaine beyond BGT-1 related to neuronal degeneration and memory impairment are the focus of this work. With this review, we underline the scarcity of detailed molecular and cellular information about betaine action. Consequently, the requirement of detailed focus on and study of the interaction of this molecule with CNS components to sustain the therapeutic use of betaine.
Abstract licence: CC BY-NC-ND
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Pharmacology and chemical data from DrugBank
Key facts
Drug status
Approved
Major interactions
None known
Half-life
14.38 h
Mechanism
Homocystinuria is a hereditary disorder characterized by high levels of the amino acid homocysteine.
Food interactions
1 warning
Human targets
1 target
Data: DrugBank · CC BY-NC 4.0
Pharmacokinetics at a glance
Absorption
50 mg/k
Half-life
50 mg/k
Volume of distribution
50 mg/k
[A252230]
Metabolism
Elimination
100%
[A252230]
With a slow elimination rate and assuming 100% bioavailability, the renal clearance of betaine is negligible (5% of total body clearance).
[L43110]…
Clearance
50 mg/k
[A252230]
Pharmacokinetic data: DrugBank · CC BY-NC 4.0
[L43105]
Included within the category of homocystinuria are deficiencies or defects in cystathionine beta-synthase (CBS), 5,10-methylenetetrahydrofolate reductase (MTHFR), and cobalamin cofactor metabolism (cbl).
[L43105]
Known interactions with other medications. Always consult a healthcare professional.
Showing 50 of 295 interactions
[L43105]
Symptomatic and supportive measures are recommended. In an acute toxicology study in rats, death frequently occurred at doses equal to or greater than 10,000 mg/kg.
[L43105]
The effects of betaine on long-term carcinogenicity and fertility have not been evaluated.
The following tests have not shown evidence of betaine genotoxicity: metaphase analysis of human lymphocytes, bacterial reverse mutation assay, and mouse micronucleus test.
[L43105]
Betaine transfers a methyl group via the enzyme betaine homocysteine methyl transferase (BHMT), converting homocysteine back into methionine and dimethylglycine (DMG).[A252240][L43110] In patients with homocystinuria, betaine reduces homocysteine levels and improves health outcomes.[A252235]
Patients taking betaine for several years do not show evidence of tolerance. Also, betaine concentrations are not correlated with homocysteine concentrations.[L43105] In patients with MTHFR deficiency and cbl defects, betaine may increase methionine and S-adenosyl methionine (SAM) plasma levels. Patients with CBS deficiency without a dietary restriction of methionine may accumulate excessive amounts of methionine. Clinical data shows that in patients with CBS deficiency, increased plasma methionine levels were associated with cerebral edema.[L43105][L43110]
How the body processes this drug — absorption, distribution, metabolism, and elimination
[A252230]
No significant changes in absorption kinetics were observed after repeated betaine administration (100 mg/kg/day for 5 days). The absolute bioavailability of betaine anhydrous has not been determined.
[L43110]
[A252230]
In volunteers given 100 mg/kg/day of betaine for 5 days, the distribution half-life was significantly longer, suggesting that the transport and redistribution processes of betaine were saturated.
[L43110]
[A252230]
[A252235]
[A252230]
With a slow elimination rate and assuming 100% bioavailability, the renal clearance of betaine is negligible (5% of total body clearance).
[L43110]
[A252230]
Proteins and enzymes this drug interacts with in the body
Enzymes involved in drug metabolism — important for understanding drug interactions
Proteins that transport this drug across cell membranes
PMID:7589472
May have a role in regulation of GABAergic transmission in the brain through the reuptake of GABA into presynaptic terminals, as well as in osmotic regulation. Probably also involved in renal and hepatic osmotic regulation (By similarity)
ATC A16AA06
ATC A09AB02
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Show
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Linked compound data from DrugBank Open Data (CC BY-NC 4.0)
Betaine
Additional database identifiers
Drugs Product Database (DPD)
6871
Drugs Product Database (DPD)
8811
ChemSpider
242
BindingDB
50103520
HUGO Gene Nomenclature Committee (HGNC)
HGNC:1047
GenAtlas
BHMT
GeneCards
BHMT
GenBank Gene Database
U50929
GenBank Protein Database
1522683
UniProt Accession
BHMT1_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:983
GenAtlas
BCHE
GeneCards
BCHE
GenBank Gene Database
M32391
GenBank Protein Database
1311630
Guide to Pharmacology
2471
UniProt Accession
CHLE_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:9453
GenAtlas
PRODH
GeneCards
PRODH
GenBank Gene Database
U82381
GenBank Protein Database
2677802
UniProt Accession
PROD_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:11045
GeneCards
SLC6A12
Guide to Pharmacology
932
UniProt Accession
S6A12_HUMAN
DrugBank citations
If you use DrugBank data in your research, please cite the following publications:
Show earlier publications
Structured knowledge from the free knowledge base
ATC classifications (Wikidata)
Linked open data from Wikidata (Q10860583), a free and open knowledge base operated by the Wikimedia Foundation. Data is available under the Creative Commons CC0 1.0 Public Domain Dedication.